Ligustrazine monomer against cerebral ischemia/reperfusion injury
Open Access
- 1 May 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 10 (5) , 832-840
Abstract
Ligustrazine (2,3,5,6-tetramethylpyrazine) is a major active ingredient of the Szechwan lovage rhizome and is extensively used in treatment of ischemic cerebrovascular disease. The mechanism of action of ligustrazine use against ischemic cerebrovascular diseases remains unclear at present. This study summarizes its protective effect, the optimum time window of administration, and the most effective mode of administration for clinical treatment of cerebral ischemia/reperfusion injury. We examine the effects of ligustrazine on suppressing excitatory amino acid release, promoting migration, differentiation and proliferation of endogenous neural stem cells. We also looked at its effects on angiogenesis and how it inhibits thrombosis, the inflammatory response, and apoptosis after cerebral ischemia. We consider that ligustrazine gives noticeable protection from cerebral ischemia/reperfusion injury. The time window of ligustrazine administration is limited. The protective effect and time window of a series of derivative monomers of ligustrazine such as 2-[(1,1-dimethylethyl)oxidoimino]methyl]-3,5,6-trimethylpyrazine, CXC137 and CXC195 after cerebral ischemia were better than ligustrazine.Keywords
This publication has 81 references indexed in Scilit:
- Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivoInternational Journal of Nanomedicine, 2011
- Reelin Controls Progenitor Cell Migration in the Healthy and Pathological Adult Mouse BrainPLOS ONE, 2011
- Antioxidative effect of the herbal remedy Qin Huo Yi Hao and its active component tetramethylpyrazine on high glucose-treated endothelial cellsLife Sciences, 2009
- Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: Potential therapeutic application for treatment of gliomasNeuro-Oncology, 2008
- Nuclear Factor-κB Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery OcclusionJournal of Neuroscience, 2008
- Stem cells and neonatal brain injuryCell and tissue research, 2007
- Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in miceGene Therapy, 2007
- Tetramethylpyrazine protected photoreceptor cells of rats by modulating nuclear translocation of NF-kappaB1Acta Pharmacologica Sinica, 2005
- Expression of Basic Fibroblast Growth Factor mRNA and Protein in the Human Brain following Ischaemic StrokeAngiogenesis, 2005
- N‐Methyl‐d‐Aspartate Receptor Desensitisation Is Neuroprotective by Inhibiting Glutamate‐Induced Apoptotic‐Like DeathJournal of Neurochemistry, 1998